Randomised controlled multicentre study of magnesium isoglycyrrhizinate injection in prevention of chemotherapy-related acute liver injury
Neoplasms · Liver Injury
Enrolment: 2040 · Results not recorded
Loading the evidence…
Drug
4 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.
Neoplasms · Liver Injury
Enrolment: 2040 · Results not recorded
Acute Drug Induced Liver Injury
Enrolment: 73 · Results not recorded
Drug-Induced Liver Injury
Enrolment: 174 · Results not recorded
Drug Induced Liver Injury
Enrolment: 232 · Results not recorded
Chronic Hepatitis B · Liver Inflammation
Enrolment: 480 · Results not recorded
1 studies reported at therapy level; 1 evidence entries itemised.
Model: Acute necrotising pancreatitis induced by retrograde injection of 5 per cent sodium taurocholate into the biliary-pancreatic duct, in rats fed a high-fat diet or standard rat chow; animals killed 12 h after model induction
Obesity aggravated pancreatitis-induced liver injury, and magnesium isoglycyrrhizinate pre-treatment improved liver function and attenuated hepatic oxidative stress and inflammation in obese rats.
Extraction: extract · Supplied extraction confidence: 0.75. Machine-extracted fields require source verification.